The Company is a specialized healthcare provider for correctional facilities, offering comprehensive, on-site upper and lower gastrointestinal (GD endoscopy) services for incarcerated inmates. The Company's services include gastrointestinal diagnostic, consultative, and therapeutic procedures, to address a critical need in correctional healthcare.
Location: Rocky Mountains, U.S.
Key Aspects:
- The Company maintained an impressive average adjusted EBITDA margin of 39.0% from 2022 through 2025.
- The Company’s onsite service model eliminates inmate transportation costs, reducing operating expenses for correctional facilities.
- The Company generates repeat revenue through contracts with third-party administrators (TPAs) that serve federal and state governments' department of corrections.
- The Company grew revenue at a compound annual growth rate (CAGR) of 26.7%, from 2022 to 2025.
Current Markets:
The Company operates within federal, state, and local correctional facilities in the Rocky Mountain region to provide gastrointestinal services to incarcerated inmates.
Real Estate:
The Company operates out of a 1,900 sq. ft. office space to support administrative functions. Ownership notes the office space is owned by an affiliated entity and is not expected to be included in the sale of the Company; however, the current lease is assumable post-transaction or the Company can be easily relocated.
Shareholder Objectives:
The Company is owned by a single shareholder who is seeking a buyer that can capitalize on and contribute to the future growth of the Company. The owner is active in the management of the Company and seeks to remain in their position post-sale. Ownership is open to various deal structures to facilitate a transaction.
